Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Pre-market Movers For April 4 (PSDV, SRPT, CPWR, LULU)

Gainers:

pSivida Corp. (PSDV: Quote) is surging 19 percent to $2.70. The company announced that it has signed a funded technology evaluation agreement with a global pharmaceutical company to evaluate its proprietary Durasert and Tethadur technologies for select products in ophthalmology.

Sarepta Therapeutics, Inc. (SRPT) is up 3 percent to $35.11.

Decliners:

Compuware Corp. (CPWR: Quote) ia falling nearly 4 percent to $11.58 as the company warned that its fourth quarter results would come in way below Wall Street view due to delays in closing a large number of deals. The company also lowered its fiscal year 2013 revenue and earnings outlook.

Lululemon Athletica Inc. (LULU: Quote) is down nearly 1 percent to $63.75. The company announced that its Chief Product Officer Sheree Waterson will be leaving effective April 15. Last month, the company recalled its signature black Luon fabric yoga pants and crops from stores, showrooms and online website due to fabric quality issues.

Click here to receive FREE breaking news email alerts for Lululemon Athletica Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Toyota Motor Corp. (TM, TYT.L) Thursday announced 1.1 percent decline in worldwide production for October, as there was a sharp decline in production of passenger cars in Japan. Production outside Japan improved 2.3 percent. In a separate announcement, the Japanese automaker said it will recall more... Computer and printer maker Hewlett-Packard Co. said Tuesday after the markets closed that its fourth quarter profit fell 6% from last year, as revenue declined 2%. The company's quarterly earnings per share, excluding items, came in line with analysts' expectations, but its quarterly revenue fell short of analysts' forecast. This organic and natural products company has experienced strong compounded annual growth over the last four fiscal years with its net sales growing 25% and adjusted income from continuing operations over 30%.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.